Our data demonstrate that PIP-199 similarly phenocopies FANCM depletion and that further development of similar FANCM-BTR interaction inhibitors may provide an effective and selective therapeutic strategy to target ALT cancers. The gene discussed is FANCM; the disease is cancer.